Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2021-10-01 00:00:00 ET · period of report 2021-09-30 · accession 0001209191-21-058365 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-01 | 2021-09-30 | RARE | Kassberg Thomas Richard | EVP, CBO | M - OptEx | $0.31 | +109.7K | 216.6K | +103% | +$34.0K |
| D | 2021-10-01 | 2021-09-30 | RARE | Kassberg Thomas Richard | EVP, CBO | M - OptEx | $0.00 | -109.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-30 | M | A | 109,734 | $0.31 | 216,552 | D | — | — | (F1) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-09-30 | M | D | 109,734 | $0.00 | 0 | D | $0.31 · — to 2021-11-17 | 109,734 Common Stock | (F2) The option vested with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares thereafter such that the option fully vested on the fourth anniversary of the grant date. |